Murphy Pohlad Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Murphy Pohlad Asset Management's AMGN Position: Q1 2022 in Review
Murphy Pohlad Asset Management sold out of Amgen (AMGN) in Q1 2022, closing a stake of 975 shares — an estimated $219K sold.
Murphy Pohlad Asset Management first reported a position in AMGN in Q4 2015 and held it in 25 quarters. The position peaked at $1.25M in Q1 2021. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.
- Murphy Pohlad Asset Management reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
- Murphy Pohlad Asset Management sold 975 Amgen shares in Q1 2022, an estimated $219K.
- Murphy Pohlad Asset Management first reported a position in Amgen in Q4 2015 and held it in 25 quarters.
- Murphy Pohlad Asset Management's Amgen position peaked at $1.25M in Q1 2021.
- 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.
Based on Murphy Pohlad Asset Management's 13F filing for Q1 2022, filed 5 May 2022.